Rámón Colomer - Publications, H-index & Citations

Rámón Colomer

instituto de investigación sanitaria del hospital universitario de la princesa

61H指数

385论文数

1.2W被引数

收录论文 110

发表时间

Body Mass Index and Body Fat Percentage Are Associated with Clinical Outcomes in Patients Receiving PD-1/PD-L1 Inhibitors: A Prospective Exploratory Study 体重指数和体脂百分比与接受PD-1/PD-L1抑制剂治疗患者的临床结局相关：一项前瞻性探索性研究

Journal of Personalized Medicine

IF3

2026-09-16

OAAI

Ángela Morell; Alberto Morell; Ainhoa Aranguren; Jacobo Rogado; Miguel Sampedro; Rebeca Mondéjar; Ramón Colomer; M. Paz Lorenzo; Esther Ramírez

A breast tissue-specific epigenetic clock provides accurate chronological age predictions and reveals de-correlation of age and DNA methylation in tumor-adjacent and tumor samples 乳腺组织特异性的表观遗传时钟可提供准确的年龄预测，并揭示肿瘤邻近组织和肿瘤样本中年龄与DNA甲基化的去相关性

Epigenetics

IF3.2

2026-09-11

OAAI

Leonardo D. Garma; Sonia Pernas; Bartomeu Fullana; Andrea Vethencourt; David Vicente Baz; Teresa García Manrique; Rosario García Campelo; Cristina Reboredo; Josefa Terrasa; Antonia Perello; Ramón Colomer; Desirée Jiménez; Ruth Vera García; Susana de la Cruz Sánchez; Begoña Bermejo; Marta Tapia; Santiago González Santiago; Miguel Quintela-Fandino

Final analysis of the FeDeriCa phase III study: long-term efficacy, safety and pharmacokinetics of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection, plus chemotherapy, in HER2-positive early breast cancer FeDeriCa III期研究的最终分析：在HER2阳性早期乳腺癌患者中，曲妥珠单抗和帕妥珠单抗固定剂量联合皮下注射方案联合化疗的长期疗效、安全性和药代动力学

ESMO Open

IF8.3

2026-07-31

OAAI

C. Jackisch; S.-A. Im; A. Mattar; R. Colomer; D. Stroyakovskiy; Z. Nowecki; M. De Laurentiis; J.-Y. Pierga; K.H. Jung; C. Schem; S. Heeson; I. Yan; B. Wang; E. Restuccia; A.R. Tan

Immune Phenotype in Urothelial Carcinoma: From Tumor Biology to Therapeutic Stratification 尿路上皮癌中的免疫表型：从肿瘤生物学到治疗分层

Cancers

IF4.4

2026-07-26

OAAI

Patricia Toquero; Lucía Castillo; Luis San José; Arantzazu Alfranca; Guillermo Celada; Clara Velasco; Laia Figols; Carlos Prada; María Pacheco; Pablo Gajate; Cristina Pernaut; Imanol Martínez; Ramón Colomer; Nuria Romero-Laorden

Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer 外周血单核细胞中趋化因子受体作为非小细胞肺癌免疫治疗疗效的预测生物标志物

Current Oncology 2025, Vol. 32, Page 583

IF0

2025-10-20

OAAI

Paloma Galera; Antía Iglesias-Beiroa; Berta Hernández-Marín; Dulce Bañón; Teresa Arangoa; Lucía Castillo; María Álvarez-Maldonado; Cristina Gil-Olarte; Rafael Borregón; María Iribarren; Ramon Colomer; Jacobo Rogado

Immunome profiling in prostate cancer: a guide for clinicians

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-11-20

OAAI

Manso, Luis San-Jose; Alfranca, Arantzazu; Moreno-Perez, Ignacio; Ruiz-Vico, Maria; Velasco, Clara; Toquero, Patricia; Pacheco, Maria; Zapatero, Almudena; Aldave, Diego; Celada, Guillermo; Albers, Eduardo; de la Maza, Maria-Dolores Fenor; Garcia, Jorge; Castro, Elena; Olmos, David; Colomer, Ramon; Romero-Laorden, Nuria

High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer

CLINICAL CANCER RESEARCH

IF10.2

2024-09-16

PREAI

Quintela-Fandino, Miguel; Bermejo, Begona; Zamora, Esther; Moreno, Fernando; Garcia-Saenz, Jose angel; Pernas, Sonia; Martinez-Janez, Noelia; Jimenez, Desiree; Adrover, Encarna; de Andres, Raquel; Mouron, Silvana; Bueno, Maria J.; Manso, Luis; Vinas, Gemma; Alba, Emilio; Llombart-Cussac, Antonio; Cortes, Javier; Tebar, Cristina; Roe, Denise J.; Grant, Adam; Watson, Adam; Colomer, Ramon; Mouneimne, Ghassan

Constructing a high-definition patient-digital twin (PDT) in treatment-naive women with advanced cancer 在治疗初期的晚期癌症女性患者中构建高分辨率患者数字孪生（PDT）

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Garma, L. D.; Jimenez, D.; Vicente Baz, D.; Vera, R.; Bermejo, B.; Gonzalez, S.; Pernas Simon, S.; Sanchez Torres, J. M.; Nasarra-Lopez, B.; Fullana Grimalt, B.; Rodriguez, M.; de la Cruz, S.; Paz, L.; Sauras, M.; Villalba, M. A.; Artes-Rodriguez, A.; Colomer Bosch, R.; Quintela-Fandino, M.

The role of the CXCL12/CXCR4 pathway in the immunotherapy of non-small cell lung cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Rogado, J.; Pozo, F.; Troule, K.; Pacheco, M.; Adrados, M.; Torres, J. M. Sanchez; Al-Shahrour, F.; Alfranca, A.; Laorden, N. Romero; Bosch, R. Colomer

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement 下一代测序检测在癌症患者中的有用性和现实世界结果: 基于临床判断的选择影响的观察性研究

ECLINICALMEDICINE

IF10

2023-06-01

OAAI

Colomer, Ramon; Miranda, Jesus; Romero-Laorden, Nuria; Hornedo, Javier; Gonzalez-Cortijo, Lucia; Mouron, Silvana; Bueno, Maria J.; Mondejar, Rebeca; Quintela-Fandino, Miguel

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A

NATURE COMMUNICATIONS

IF15.7

2022-12-07

OAAI

Mouron, S.; Bueno, M. J.; Lluch, A.; Manso, L.; Calvo, I; Cortes, J.; Garcia-Saenz, J. A.; Gil-Gil, M.; Martinez-Janez, N.; Apala, J., V; Caleiras, E.; Ximenez-Embun, Pilar; Munoz, J.; Gonzalez-Cortijo, L.; Murillo, R.; Sanchez-Bayona, R.; Cejalvo, J. M.; Gomez-Lopez, G.; Fustero-Torre, C.; Sabroso-Lasa, S.; Malats, N.; Martinez, M.; Moreno, A.; Megias, D.; Malumbres, M.; Colomer, R.; Quintela-Fandino, M.

Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Manso, Luis; Cortes, Alfonso; Cejalvo, Juan M.; Morales, Serafin; Saenz, Jose A. Garcia; Colomer, Ramon; Sanchez-Bayona, Rodrigo; Silva, Jorge; Guerra, Juan A.; Malon, Diego; Mouron, Silvana; Caleiras, Eduardo; Quintela-Fandino, Miguel

Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Rogado, J.; Pozo, F.; Troule, K.; Sanchez-Torres, J. M.; Romero Laorden, N.; Mondejar Solis, R.; Donnay Candil, O.; Ballesteros Garcia, A. I.; Pacheco-Barcia, V.; Aspa, J.; Al-Shahrour, F.; Alfranca, A.; Colomer, R.

Emotional distress in cancer patients during the first wave of the COVID-19 pandemic in Madrid

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Diez, P. Toquero; Fernandez, C. Blanco; Cea, B. Vera; Carrascosa, E. Mendez; Garcia, A. Garrido; Candil, O. Donnay; Garcia, A. I. Ballesteros; Sanchez-Torres, J. M.; Rojo, P. Costas; Solis, R. Mondejar; Hernandez, B.; Marti, M. D. P. Lopez; Bosch, R. Colomer; Laorden, N. Romero

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

ANNALS OF ONCOLOGY

IF65.4

2021-05-01

OAAI

Im, S-A.; Tan, A. R.; Mattar, A.; Colomer, R.; Stroyakovskii, D.; Nowecki, Z.; De Laurentiis, M.; Pierga, J-Y.; Jung, K. H.; Schem, C.; Aguila, C.; Crnjevic, T. Badovinac; Heeson, S.; Shivhare, M.; Alexandrou, A.; Restuccia, E.; Jackisch, C.

Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial

ANNALS OF ONCOLOGY

IF65.4

2021-05-01

OAAI

Dang, C.; Ewer, M. S.; Delaloge, S.; Ferrero, J-M.; Colomer, R.; de la Cruz Merino, L.; Dadswell, K.; Verrill, M.; Eiger, D.; Sarkar, S.; de Haas, S.; Restuccia, E.; Swain, S. M.

The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-13

OAAI

Grunt, Thomas W.; Lemberger, Lisa; Colomer, Ramon; Lopez-Rodriguez, Maria Luz; Wagner, Renate

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

BREAST CANCER RESEARCH

IF5.6

2021-02-12

OAAI

Mouron, Silvana; Manso, Luis; Caleiras, Eduardo; Rodriguez-Peralto, Jose L.; Rueda, Oscar M.; Caldas, Carlos; Colomer, Ramon; Quintela-Fandino, Miguel; Bueno, Maria J.

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial 免疫引发durvalumab联合贝伐单抗治疗HER2-negative晚期乳腺癌的临床试验

BREAST CANCER RESEARCH

IF5.6

2020-11-11

OAAI

Quintela-Fandino, Miguel; Holgado, Esther; Manso, Luis; Morales, Serafin; Bermejo, Begona; Colomer, Ramon; Apala, Juan V.; Blanco, Raquel; Munoz, Manuel; Caleiras, Eduardo; Iranzo, Vega; Martinez, Mario; Dominguez, Orlando; Hornedo, Javier; Gonzalez-Cortijo, Lucia; Cortes, Javier; Gasol Cudos, Ariadna; Malon, Diego; Lopez-Alonso, Antonio; Moreno-Ortiz, Maria C.; Mouron, Silvana; Manes, Santos

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

SCIENTIFIC REPORTS

IF3.9

2020-09-10

OAAI

Grunt, Thomas W.; Slany, Astrid; Semkova, Mariya; Colomer, Ramon; Luz Lopez-Rodriguez, Maria; Wuczkowski, Michael; Wagner, Renate; Gerner, Christopher; Stuebiger, Gerald

研究方向